Relugolix combination therapy shown more effective than monotherapyStudy finds once-daily relugolix combination therapy reduces menstrual bleeding in women with uterine fibroids,with less bone mineral density loss than with monotherapy. Isolation and sanitation during COVID-19 may affect human microbiome, scientists say Decade's worth of Ontario health data finds more severe disease, younger patients Ontario's vaccine rollout could look different across health units: Solicitor General Nova Scotia expands access to COVID-19 vaccine to people 80 years old and older There’s POWER in physician-patient interactions Virtual event on history of Black Canadians' experiences with healthcare Overview of recent oral oncology drugs An overview of new oral targeted cancer therapies for community pharmacists Innovators: Building a better home for Indigenous health PEI chooses TELUS Health to provide province-wide EMR solution First Previous 684 685 686 687 688 Next Last
